Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bonneterre

Showing results (81-90 of 194) with videos related to

Pageof 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2011
Is adjuvant chemotherapy useful in lobular breast cancer patients?X Liem, M C Baranzelli, N Penel, et al.
Bulletin Du Cancer|January 1, 1992
[FGFB binding sites in cancers of the human breast]J P Peyrat, H Hondermarck, B Hecquet, et al.
American Journal of Clinical Oncology|June 1, 1992
Aminoglutethimide in malignant melanoma. A phase II studyS Block, J Bonneterre, A Adenis, et al.
Bulletin Du Cancer|March 5, 2009
[Male breast cancer: a review]B Comet, B Cutuli, F Penault-Llorca, et al.
LARC Medical|May 1, 1982
[Normal and pathologic metabolism of pteridines in man]J L Dhondt, Z Bellhasene, C Largilliere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2010
Return to work after treatment for breast cancer: single-center experience in a cohort of 273 patientsC Peugniez, S Fantoni, A Leroyer, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1985
Transferrin receptors in cultured breast cancer cellsB Vandewalle, A M Granier, J P Peyrat, et al.
Bulletin Du Cancer|March 1, 1994
Loss of efficacy of ondansetron-dexamethasone during successive courses in female patients receiving high-dose cisplatinV Chevalier-Evain, J Bonneterre, A Adenis, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1981
Dihydropteridine-reductase activity in breast cancer. Preliminary reportJ L Dhondt, J Bonneterre, J P Farriaux, et al.
Cancer Research|September 1, 1983
Nuclear estradiol-binding sites in human breast cancerB Vandewalle, J P Peyrat, J Bonneterre, et al.
Pageof 20

Showing results (81-90 of 194) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2011
Is adjuvant chemotherapy useful in lobular breast cancer patients?X Liem, M C Baranzelli, N Penel, et al.
Bulletin Du Cancer|January 1, 1992
[FGFB binding sites in cancers of the human breast]J P Peyrat, H Hondermarck, B Hecquet, et al.
American Journal of Clinical Oncology|June 1, 1992
Aminoglutethimide in malignant melanoma. A phase II studyS Block, J Bonneterre, A Adenis, et al.
Bulletin Du Cancer|March 5, 2009
[Male breast cancer: a review]B Comet, B Cutuli, F Penault-Llorca, et al.
LARC Medical|May 1, 1982
[Normal and pathologic metabolism of pteridines in man]J L Dhondt, Z Bellhasene, C Largilliere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2010
Return to work after treatment for breast cancer: single-center experience in a cohort of 273 patientsC Peugniez, S Fantoni, A Leroyer, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1985
Transferrin receptors in cultured breast cancer cellsB Vandewalle, A M Granier, J P Peyrat, et al.
Bulletin Du Cancer|March 1, 1994
Loss of efficacy of ondansetron-dexamethasone during successive courses in female patients receiving high-dose cisplatinV Chevalier-Evain, J Bonneterre, A Adenis, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1981
Dihydropteridine-reductase activity in breast cancer. Preliminary reportJ L Dhondt, J Bonneterre, J P Farriaux, et al.
Cancer Research|September 1, 1983
Nuclear estradiol-binding sites in human breast cancerB Vandewalle, J P Peyrat, J Bonneterre, et al.
Pageof 20